Home
 
Materials  
Toctino®▼ Pregnancy Prevention Programme (PPP) and other Materials  

This page is intended for healthcare professionals

Toctino® (alitretinoin), distributed by Basilea Pharmaceuticals Ltd., is licensed in the United Kingdom as an oral treatment for patients suffering from severe chronic hand eczema that does not respond to potent topical corticosteroid therapy.

Toctino® (alitretinoin) is a naturally occurring, physiologic derivative of vitamin A and belongs to the well studied family of retinoids, which are all teratogens; therefore, Toctino® (alitretinoin) is strictly contraindicated in women of child-bearing potential unless strict pregnancy testing and contraception is followed before, during and one month after cessation of treatment.

The product information on this site is intended for healthcare professionals only. Please also consult the Toctino® (alitretinoin) Summary of Product Characteristics and the Toctino Patient Information Leaflet for further details. Patients or non-healthcare persons should consult their doctor or other medical professional about treatment and therapies.

PPP Dear Healthcare Professional cover letter

PPP Guidance for Doctors and Pharmacists

PPP Patient Information

PPP Information About Contraception

PPP Acknowledgement Form for Female Patients

PPP Checklist for prescribing to Female Patients

Toctino Patient Booklet

Toctino Pack Patient information Leaflet PIL

NICE Guidance for Toctino

PGA & DLQI Rating Scales

UK Summary of Product Characteristics (datasheet) Toctino (alitretinoin)



 

If you need any further information or assistance, and you are a qualified healthcare professional, please contact our Medical Information or Drug Safety team.

General Contact

Basilea Pharmaceuticals Ltd.
14/16 Frederick Sanger Road
The Surrey Research Park
Guildford
Surrey, GU2 7YD
UK
T: +44 1 483 600 095
F: +44 1 483 505 365
email: Office.uk@basilea.com

Medical information

Medical Information
Basilea Pharmaceuticals Ltd.
 
T: +44 1 483 790023
F: +44 1 483 505345

Drug Safety

Drug Safety
Basilea Pharmaceuticals Ltd.
 
T: +44 1 483 790023
F: +44 1 483 505345
 

General Disclaimers

The information on this site is provided "as is" without any warranties, expressed or implied. In particular, Basilea Pharmaceutica Ltd. and/or its subsidiaries ("Basilea") make no representation or warranty that the information contained on this site will be timely, complete or error-free. To the extent permitted by applicable laws, Basilea accepts no liability whatsoever in respect of any loss, damage or expenses arising from your use of this site or the unavailability of this site.

Applicable Laws

This site contains information about pharmaceutical products, treatments and therapies, which may or may not be available in other countries. Each country has specific laws, regulations and medical practices governing the communication of medical or other information on the Internet. Nothing in this site should be viewed as a solicitation or promotion of any particular pharmaceutical product, treatment or therapy, which is not authorized, by the laws and regulations of the country where the reader resides, or as a promotion or advertisement of any pharmaceutical products or services.

Health Information

This site contains information on medical and health-related topics. This information of this site is intended for healthcare professionals only. This information is not meant to be a substitute for the advice provided by your own doctor or other medical professional. You should not use this information for diagnosing a health problem or disease but always consult your own doctor.

Links to Other Web Sites

Basilea can direct you to external web sites. Basilea does not own these sites. Basilea does not necessarily endorse and is not responsible for the content of any offsite pages or any other sites linked to these sites. Use of linked sites that are not owned or operated by Basilea is at your own risk and Basilea will not be liable for any loss, damage or expenses, which you suffer or incur as a result of your use of such sites.
© 2008 Basilea Pharmaceutica Ltd.